COR Therapeutics

(CORR) - Get CorEnergy Infrastructure Trust, Inc. Report

posted fourth-quarter earnings Tuesday that were slightly above Wall Street estimates.

The pharmaceutical products company said it earned 2 cents a share for the quarter, significantly better than the 11-cent-a-share loss posted in the year-ago period. Six analysts polled by

First Call/Thomson Financial

TheStreet Recommends

were expecting the company to earn a penny in the quarter.

Shares of COR lost $1.19, or 2.8%, to $40.88 in recent

Nasdaq

trading.